ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "T cells"

  • Abstract Number: 949 • 2013 ACR/ARHP Annual Meeting

    Targeting CD1c-Expressing Mdcs To Inhibit Tcell Activation and Thymus and Activation Regulated Chemokine (TARC)-Dependent Chemotaxis In RA

    M.R. Hillen1,2, F.M. Moret1,3, F.P.J.G. Lafeber4, C.E. Hack4, T.R.D.J. Radstake2,5 and J.A.G. van Roon3,6, 1Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 4Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, Netherlands, 5Laboratory for Translational Immunology, UMC Utrecht, Utrecht, Netherlands, 6Laboratory for Translational immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Recently, we demonstrated strong Th1 and Th17 cytokine induction by CD1c+ myeloid dendritic cells (mDCs) from synovial fluid and identified thymic stromal lympopoeitin (TSLP)…
  • Abstract Number: 666 • 2013 ACR/ARHP Annual Meeting

    Involvement Of TCR Vdelta1+ NKT Cells In Systemic Sclerosis: Association With Interstitial Pneumonia

    Seiji Segawa1, Daisuke Goto2, Masanobu Horikoshi2, Yuya Kondo3, Naoto Umeda2, Shinya Hagiwara2, Masahiro Yokosawa4, Tomoya Hirota3, Haruka Miki1, Hiroto Tsuboi3, Hiroshi Ogishima2, Takeshi Suzuki4, Isao Matsumoto5 and Takayuki Sumida3, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 2Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba City, Japan, 3Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 4Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 5Department of Internal Medicine, Faculty of Medicine,, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: Interstitial pneumonia (IP) is one of the critical complications in patients with several autoimmune diseases. However, the exact mechanism of IP remains elusive. Recently,…
  • Abstract Number: 172 • 2013 ACR/ARHP Annual Meeting

    Transcript Profiling Of Kidney Biopsies From Chinese Patients With Lupus Nephritis Suggests a Prevalence Of Infiltrating CD8+ T Cells, Monocytes/Macrophages, and B Cells In ISN/RPS Class IV Disease

    Zheng Liu1, Chris Morehouse1, Xinfang Huang2, Philip Brohawn1, Nan Shen3, Gabor G. Illei4, Yihong Yao1 and Brandon W. Higgs1, 1Translational Sciences, MedImmune, LLC, Gaithersburg, MD, 2Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, 3Division of Rheumatology & the Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Medical Center, cincinnati, OH, 4Clinical Development, MedImmune, LLC, Gaithersburg, MD

    Transcript profiling of kidney biopsies from Chinese patients with lupus nephritis suggests a prevalence of infiltrating CD8+ T cells, monocytes/macrophages, and B cells in ISN/RPS…
  • Abstract Number: 2055 • 2013 ACR/ARHP Annual Meeting

    Killer T Cell Inhibition By CD226 Blockade For Treatment Of Inflammatory Myopathy

    Hitoshi Kohsaka1, Nao Tateishi1, Shinya Hirata2, Kazuko Shibuya3, Akira Shibuya3 and Nobuyuki Miyasaka4, 1Department of Medicine and Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan, 2Department of Rheumatology and Clinical Immunology, Kumamoto University School of Medicine, Kumamoto, Japan, 3Department of Immunology, University of Tsukuba, Ibaraki, Japan, 4Tokyo Medical and Dental University, Tokyo, Japan

    Background/Purpose: Current treatment strategy of polymyositis/dermatomyositis calls for administration of high dose glucocorticoids and additional immunosupressants when necessary. These options are based largely on successful…
  • Abstract Number: 929 • 2013 ACR/ARHP Annual Meeting

    Blockade Of TNFα Produced By TSLP-Primed CD1c Myeloid Dendritic Cells Skews T Cell Response To Th2 Activity In Rheumatoid Arthritis Patients

    F.M. Moret1, T.R.D.J. Radstake2, J.W.J. Bijlsma1, F.P.J.G. Lafeber1 and J.A.G. van Roon3, 1Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Rheumatology & Clinical Immunology/Lab Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Thymic stromal lymphopoietin (TSLP) is well known for its potent activation of myeloid dendritic cells (mDCs) to induce Th2-mediated immune responses. Additionally, TSLP and…
  • Abstract Number: 661 • 2013 ACR/ARHP Annual Meeting

    Topoisomerase-1 Specific T Cells Exhibit a Proinflammatory Th17 Phenotype and Are Associated With Interstitial Lung Disease In Scleroderma

    Andrea Fava1, Raffaello Cimbro1, Antony Rosen2, Qing-Rong Liu3, Fredrick M. Wigley2 and Francesco Boin2, 1Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 2Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3NIH/NIDA, Baltimore, MD

    Background/Purpose: Anti-topoisomerase-1 (Topo-1 or Scl70) autoantibodies are present in 30-45% of scleroderma (SSc) patients and identify a more aggressive disease phenotype with worse clinical outcome…
  • Abstract Number: 1853 • 2013 ACR/ARHP Annual Meeting

    Functions Of Aminopeptidase N/CD13 In Vitro On Rheumatoid Arthritis Synovial Cells

    Rachel Morgan1, Nilofar Behbahani-Nejad2, Judith Endres3 and David A. Fox4, 1Immunology, University of Michigan, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI, 3Rheumatology/Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, 4Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

    Background/Purpose: Aminopeptidase N (CD13, EC 3.4.11.2) is a metalloproteinase expressed on the surface of fibroblast like synoviocytes (FLS) that is also found in soluble form…
  • Abstract Number: 942 • 2013 ACR/ARHP Annual Meeting

    CXCL13 Is a Marker Of Joint Involvement In Early Rheumatoid Arthritis

    Stinne Greisen1, Tue Rasmussen1, Karen Schelde1, Kristian Stengaard-Pedersen2, Merete Lund Hetland3, Kim Hørslev-Petersen4, Bent Deleuran5 and Malene Hvid6, 1Dept of Biomedicine, Aarhus University, Aarhus, Denmark, 2Arhus University Hospital, Aarhus, Denmark, 3Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, The Danish Rheumatologic Database (DANBIO), Glostrup Hospital., Copenhagen, Denmark, 4Institute of Regional Health Services Research, University of Southern Denmark, Graasten, Denmark, 5Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 6Dept. of Clinical Medicine, Aarhus University, Aarhus, Denmark

    Background/Purpose: CXCL13 is central in the formation of lymphoid follicles in secondary and tertiary lymphoid tissue. It attracts CXCR5-expressing B cells and follicular helper T…
  • Abstract Number: 568 • 2013 ACR/ARHP Annual Meeting

    Pneumococcal Polysaccharide Vaccination Regulates T and B Lymphocyte Cytokine Responses and Decreases Kidney Stat1 Levels In MRL/Lpr Mice In Vivo

    Victor Gazivoda1, Shikha Mehta2, Luhan Wang3, Julia Ash4, Kirk E. Sperber3 and Ioannis Tassiulas3, 1Medicine, New York Medical College, Valhalla, NY, 2New York Medical College, Valhalla, NY, 3Medicine-Rheumatology, New York Medical College, Valhalla, NY, 4Rheumatology, New York Medical College, Valhalla, NY

    Background/Purpose: Zwitterionic polysaccharides can activate CD4+ T cells after processing and presentation by antigen-presenting cells. The 23-valent capsular polysaccharide pneumococcal vaccine, PneumoVax, protects against invasive…
  • Abstract Number: 1859 • 2013 ACR/ARHP Annual Meeting

    OX40+ T Cells and OX40L+ B Cells Accumulate In The Inflamed Joints and OX40 Signalling Is Skewed Towards Autoreactivity

    Julie Kristine Laustsen1, Tue Rasmussen2, Malene Hvid3 and Bent Deleuran4, 1Department of Medical Biomedicine, Aarhus University, Aarhus N, Denmark, 2Dept of Biomedicine, Aarhus University, Aarhus, Denmark, 3Dept. of Clinical Medicine, Aarhus University, Aarhus, Denmark, 4Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by the presence of autoantibodies and autoreactive T cells, leading to synovitis and joint destruction. The…
  • Abstract Number: 813 • 2013 ACR/ARHP Annual Meeting

    Citrulline Specific CD4+ T Cells Exhibit a Th1 Memory Phenotype In Rheumatoid Arthritis Subjects and Their Ex Vivo Frequency Is Influenced By Both Disease Duration and Biologic Therapy

    Eddie James1, Mary Rieck2, Jennifer Pieper3, John Gebe4, Betty Yue4, Megan Tatum5, Charlotta Sandin6, Lars Klareskog7, Vivianne Malmström8 and Jane Buckner9, 1Benaroya Research Institute, Seattle, WA, 2Translational Research Program, Benaroya Research Institute, Seattle, WA, 3Department of Medicine, Karolinska Institutet, Rheumatology Unit, Stockholm, Sweden, 4Diabetes Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, 6Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 7Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 8Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 9Translational Research Program, Benaroya Research Institute, Seattle, WA 98101, USA,, Seattle, WA

    Background/Purpose: Rheumatoid arthritis is thought to be a T cell mediated disease, based on its strong association with HLA class II alleles, clinical responsiveness to…
  • Abstract Number: 545 • 2013 ACR/ARHP Annual Meeting

    Preferential Infiltration Of Double-Negative (DN) T Cells Into The Glomeruli Of NZM 2328 Lupus Mice

    Ning Yu, Shunhua Guo, William Stohl and Chaim O. Jacob, Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA

    Background/Purpose: Lupus nephritis affects at least 50% of patients with SLE and is a major cause of morbidity. The pathologic picture of lupus nephritis is…
  • Abstract Number: 2893 • 2013 ACR/ARHP Annual Meeting

    Intestinal Microbiota Plays a Critical Role In The Production Of Antinuclear Antibodies In Lymphopenia-Induced Autoimmunity

    Toshiki Eri1, Kimito Kawahata1, Mitsuru Imamura1, Takeyuki Kanzaki2, Lisa Akahira1, Kazuya Michishita1, Makoto Dohi1, Takeshi Tokuhisa3 and Kazuhiko Yamamoto4, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Internal Medicine, Yamanashi Prefectural Central Hospital, Yamanashi, Japan, 3Development Genetics, Graduate School of Medicine, Chiba University, Chiba city, Chiba, Japan, 4Department of Allergy and Rhaumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    Background/Purpose: Production of antinuclear autoantibodies (ANAs) is one of the major characteristics of the systemic autoimmune diseases, such as systemic lupus erythematosus (SLE), but the…
  • Abstract Number: 1763 • 2013 ACR/ARHP Annual Meeting

    IL4-10 Synerkine: A Novel Immunoregulatory Drug To Prevent Immunopathology In Rheumatic Diseases

    Sarita Hartgring1, Cristine Steen-louws2, C.E. Hack3, Martin De Smet4, Floris Lafeber5 and J.A.G. van Roon6, 1Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatology & Clinical Immunology/Lab Translational Immunology, UMC Utrecht, Utrecht, Netherlands, 3Immunology, UMC Utrecht, Utrecht, Netherlands, 4Lab Translational Immunology, UMC Utrecht, Utrecht, Netherlands, 5Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, Netherlands, 6Rheumatology & Clinical Immunology/Lab Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: A considerable percentage of patients shows a limited response to biologics targeting one specific inflammatory mediator, largely because of redundancy of these mediators. An…
  • Abstract Number: 727 • 2013 ACR/ARHP Annual Meeting

    Adiponectin Promotes The Differentiation Of naïve T Cell To Th17 Cell and Aggravates Collagen-Induced Arthritis

    Miaojia Zhang1, Xiaoxuan Sun2, Wenfeng Tan3, Xiaoke Feng4 and Ke Gan5, 1Department of Rheumatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, CHINA., Nanjing, China, 2Department of Rheumatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, CHINA, Nanjing, China, 3Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, 4Rheumatology, the First Affiliated Hospital of Nanjing Medical University, China, Nanjing, China, 5Rheumatology Department, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China

    Background/Purpose: To investigate a role of Adiponectin (AD) on the differentiation of naïve T cell to Th17 cell and bone erosion in collagen-induced arthritis (CIA)…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 32
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology